| Literature DB >> 31118458 |
C Frese1, T Wohlrab2, L Sheng3, M Kieser3, J Krisam3, D Wolff4.
Abstract
This 4-year randomized controlled trial (RCT) aimed at investigating whether routine home use of both a SnCl2/AmF/NaF-containing mouth rinse and toothpaste has a preventive effect on oral health. Fifty-four test subjects were examined in biannual intervals. The primary endpoint "dental erosion" was determined by the Basic Erosive Wear Examination (BEWE). The secondary endpoints were "saliva pH", "dentin hypersensitivity" generated by Visual Analogue Scale (VAS), and "discoloration" measured by the Lobene Stain Index (LSI). A mixed model for repeated measures (MMRM) was used to analyze the primary endpoint "dental erosion". Primary analysis showed a significant intervention effect of the SnCl2/AmF/NaF-containing test product (p1 = 0.0242). This result was confirmed by two additional MMRM-based sensitivity analyses. Comparison of all models showed "dental erosion" values of the intervention group below values of the control group. Discoloration of the teeth was significantly higher in the intervention than in the control group at all time points. Saliva pH and dentin hypersensitivity were not significantly different between groups over four years. In summary, this RCT is the first to indicate a possible preventive effect of SnCl2/AmF/NaF-containing oral hygiene products on dental erosion over a follow-up period of four years.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31118458 PMCID: PMC6531450 DOI: 10.1038/s41598-019-44164-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Depicts the CONSORT flow diagram, the adverse events as well as the reasons for withdrawal. With 19 patients withdrawing from the study, the overall dropout rate was 35.19%, with 7 subjects resigning from the control, and 12 subjects from the test group. Six control subjects missed one follow-up appointment each, but continued to participate in the remaining follow-up examinations afterwards[23].
Descriptive display of the variables at baseline (t = 0).
| Variable | Control n = 27 | Intervention n = 27 | Total n = 54 | p-value* |
|---|---|---|---|---|
|
| ||||
| - Mean +/− SD | 36.26 +/− 8.68 | 34.44 +/− 10.01 | 35.35 +/− 9.32 | 0.387 |
| - Median | 36 | 34 | 35,5 | |
| - Min, Max | 22, 52 | 20, 57 | 20, 57 | |
|
| ||||
| - Male | 24 (88.9%) | 17 (63.0%) | 41 (75.9%) | 0.026 |
| - Female | 3 (11.1%) | 10 (37.0%) | 13 (24.1%) | |
|
| ||||
| - Mean +/− SD | 8.22 +/− 3.15 | 8.67 +/− 3.10 | 8.44 +/− 3.11 | 0.675 |
| - Median | 8 | 8 | 8 | |
| - Min, Max | 3, 18 | 4, 15 | 3, 18 | |
|
| ||||
| - Mean +/− SD | 6.78 +/− 0.38 | 6.70 +/− 0.33 | 6.74 +/− 0.36 | 0.639 |
| - Median | 6.80 | 6.80 | 6.80 | |
| - Min, Max | 5.80, 7.60 | 5.80, 7.40 | 5.80, 7.60 | |
|
| ||||
| - Mean +/− SD | 4.36 +/− 2.08 | 4.56 +/− 2.33 | 4.46 +/− 2.19 | 0.760 |
| - Median | 4 | 5 | 5 | |
| - Min, Max | 1, 9 | 1, 10 | 1, 10 | |
*p-values were calculated using the Wilcoxon-Mann-Whitney test for continuous variables, and the chi-squared test for categorical variables.
Figure 2Boxplots for the primary endpoint BEWE over time. ∆ = arithmetic mean. N: Number of observations in the control group/intervention group.
Results of the statistical evaluation of the primary endpoint with three models showing type 3 test-based p-values (primary and model with additional covariates as well as the model after multiple imputation).
| Effect | Primary model | Model with additional covariates | Multiple imputation model |
|---|---|---|---|
| p1-value | p2-value | p3-value | |
|
| |||
| Group (intervention SnCl2/AmF/NaF) | *0.0242 | *0.0338 | *0.0259 |
| Time of examination | ** < 0.0001 | ** < 0.0001 | |
| Group*time of examination | 0.5970 | 0.8113 | |
| BEWE at t = 0 | ** < 0.0001 | ** < 0.0001 | ** < 0.0001 |
| pH value | 0.9650 | 0.7470 | 0.8681 |
| Age | 0.2977 | ||
| Gender | *0.0294 | ||
| Saliva flow [ml/min] | 0.7937 | ||
| Hypersensitivity by VAS | 0.3367 | ||
Parameter estimates for fixed effects in the primary and enhanced model.
| Effect | Primary model | Model with additional covariates | Multiple imputation model | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Estimates | Standard error | p-value | Estimates | Standard error | p-value | Estimates | Standard error | p-value | |
|
| |||||||||
| BEWE at t = 0 | 0.7740 | 0.0876 | ** < 0.0001 | 0.7563 | 0.1146 | ** < 0.0001 | 0.7897 | 0.1117 | ** < 0.0001 |
| pH value | 0.0115 | 0.2607 | 0.9650 | −0.0906 | 0.2802 | 0.7470 | 0.0908 | 0.5464 | 0.8681 |
| Age | −0.0378 | 0.0358 | 0.2977 | ||||||
| Gender Female | 1.9508 | 0.8680 | *0.0294 | ||||||
| Male | 0 | . | . | ||||||
| Saliva flow [ml/min] | −0.0348 | 0.1325 | 0.7937 | ||||||
| Hypersensitivity | 0.0884 | 0.0917 | 0.3367 | ||||||
Figure 3(a–c) Estimates of the least squares means with 95% confidence intervals concerning the group differences of the BEWE for all three linear models: (a) primary model; (b) model with additional covariates; and (c) multiple imputation. The p-value at every point in time is depicted below the respective confidence interval.
Figure 4(a–c) Boxplots of the secondary endpoint saliva pH value; (b) Chronological sequence of the secondary endpoint hypersensitivity; and (c) Chronological sequence of the secondary endpoint Lobene Stain Index over time. ∆ = arithmetic mean. N: Number of observations in the control group/intervention group.
Parameter estimates and type-III-test based p-values of fixed effects of the secondary endpoints saliva pH, dentin hypersensitivity (DHS), and discolorations (DC).
| Estimate | Saliva pH Std.error | p-value | Estimate | DHS Std.error | p-value | Estimate | DC Std.error | p-value | |
|---|---|---|---|---|---|---|---|---|---|
| Group (intervention SnCl2) | 0.1034 | 0.1693 | *0.0010 | ||||||
| Time of examination | 0.5209 | 0.0970 | *0.0155 | ||||||
| Group*time of examination | 0.3761 | 0.9323 | 0.7147 | ||||||
| BEWE at baseline examination | 0.0151 | 0.0138 | 0.2812 | −0.0463 | 0.0833 | 0.5809 | −0.0033 | 0.0157 | 0.8351 |
| pH value at baseline examination | 0.5303 | 0.1188 | ** < 0.0001 | −0.1077 | 0.7176 | 0.8814 | 0.0860 | 0.1348 | 0.5274 |
| Hypersensitivity at baseline examination | −0.0184 | 0.0180 | 0.3141 | 0.4976 | 0.1142 | ** < 0.0001 | −0.0109 | 0.0207 | 0.5988 |
Note: Due to the variables’ cateogrical scale level, estimates for time and the treatment group*time interaction are not provided.
Figure 5Clinical presentation of extrinsic discoloration in the test subjects, ranging from light to heavy at the examination times prior to tooth cleaning.